Amanote Research
Register
Sign In
Intestinal Microbiota Predicts Lung Cancer Patients at Risk of Immune-Related Diarrhea
Immunotherapy
- United Kingdom
doi 10.2217/imt-2018-0144
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Allergy
Immunology
Date
April 1, 2019
Authors
Tian Liu
Qi Xiong
Lingling Li
Yi Hu
Publisher
Future Medicine Ltd
Related search
Microbiota Intestinal De Ovinos Hígidos E Com Diarreia / Intestinal Microbiota of Healthy and Diarrhea Suffering Sheep
Ars Veterinaria
Luminal and Mucosal-Associated Intestinal Microbiota in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
Gut Pathogens
Virology
Parasitology
Infectious Diseases
Microbiology
Gastroenterology
Peripheral Immune Cell Gene Expression Predicts Survival of Patients With Non-Small Cell Lung Cancer
PLoS ONE
Multidisciplinary
Lung Microbiota Promote Lung Cancer
Cancer Discovery
Oncology
Incidence, Risk Factors, and Impact on Survival of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Preoperative Immune-Nutritional Abnormality Predicts Poor Outcome in Elderly Non-Small-Cell Lung Cancer Patients With Comorbidities
Annals of Thoracic and Cardiovascular Surgery
Gastroenterology
Cardiology
Cardiovascular Medicine
Medicine
Pulmonary
Respiratory Medicine
Surgery
Immune Dysregulation in Cancer Patients Developing Immune-Related Adverse Events
British Journal of Cancer
Cancer Research
Oncology
Treatment- And Immune-Related Adverse Events of Immune Checkpoint Inhibitors in Advanced Lung Cancer
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Peripheral Blood Markers Identify Risk of Immune‐Related Toxicity in Advanced Non‐Small Cell Lung Cancer Treated With Immune‐Checkpoint Inhibitors
Oncologist
Cancer Research
Medicine
Oncology